Neutrophil-to-lymphocyte ratio associated with an increased risk of mortality in patients with critical limb ischemia

por Su, Min-I., Liu, Cheng-Wei
Publicado 2021

Endovascular interventions may save limbs in elderly subjects with severe lower extremity arterial disease

por SU, Min-I, LIU, Cheng-Wei
Publicado 2021

The Impact of SYNTAX Score of Non-Infarct-Related Artery on Long- Term Outcome among Patients with Acute ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous...

por Su, Min-I, Tsai, Cheng-Ting, Yeh, Hung-I, Chen, Chun-Yen
Publicado 2014

The Impact of Atrial Fibrillation on One-Year Mortality in Patients with Severe Lower Extremity Arterial Disease

por Su, Min-I, Cheng, Ying-Chih, Huang, Yu-Chen, Liu, Cheng-Wei
Publicado 2022

Reduced-Dose Rivaroxaban Is Associated with Lower All-Cause Mortality in Older Patients with Nonvalvular Atrial Fibrillation

por Chiou, Wei-Ru, Su, Min-I, Lee, Ying-Hsiang, Lin, Po-Lin, Liu, Cheng-Wei
Publicado 2023

Is endotracheal intubation a non-beneficial treatment in patients with respiratory failure due to paraquat poisoning?

por Wu, Meng-Ruey, Hsiao, Chia-Ying, Cheng, Chun-Han, Liao, Feng-Ching, Chao, Chuan-Lei, Chen, Chun-Yen, Yeh, Hung-I, Su, Min-I
Publicado 2018

Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation

por Chiou, Wei-Ru, Lin, Po-Lin, Huang, Chun-Che, Chuang, Jen-Yu, Liu, Lawrence Yu-Min, Su, Min-I, Liao, Feng-Ching, Kuo, Jen-Yuan, Tsai, Cheng-Ting, Wu, Yih-Jer, Wang, Kuang-Te, Lee, Ying-Hsiang
Publicado 2022

Author Correction: Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation

por Chiou, Wei-Ru, Lin, Po-Lin, Huang, Chun-Che, Chuang, Jen-Yu, Liu, Lawrence Yu-Min, Su, Min-I, Liao, Feng-Ching, Kuo, Jen-Yuan, Tsai, Cheng-Ting, Wu, Yih-Jer, Wang, Kuang-Te, Lee, Ying-Hsiang
Publicado 2023

Exploratory Evaluation of Rhythm Control by Dronedarone in Combination With Low-Dose Rivaroxaban, Warfarin, Antiplatelet, or None of the Antithrombotic Therapy in High-Risk Patient...

por Lin, Po-Lin, Chiou, Wei-Ru, Su, Min-I, Huang, Chun-Che, Liao, Feng-Ching, Liu, Lawrence Yu-Min, Chuang, Jen-Yu, Chen, Chun-Yen, Tsai, Cheng-Ting, Kuo, Jen-Yuan, Yang, Ten-Fang, Wu, Yih-Jer, Lee, Ying-Hsiang
Publicado 2021